NOVAVAX INC: accounts_receivable
| Value | {"amount": 1832000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2011-06-30) |
| Status | current |
| Entity | NOVAVAX INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:00.349347+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/847e888a-0ea7-472d-93c9-247033401c9c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-11-044872Retrieved: 2026-08-19T09:41:00.349347+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001000694/accounts-receivable/2011-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/847e888a-0ea7-472d-93c9-247033401c9c
History
- no predecessors — first report